EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lymph node metastasis in early invasive lung adenocarcinoma: Prediction model establishment and validation based on genomic profiling and clinicopathologic characteristics

Wei Guo iD, Tong Lu iD, Yang Song, Anqi Li, Xijia Feng iD, Dingpei Han, Yuqin Cao, Debin Sun, Xiaoli Gong, Chengqiang Li, Runsen Jin, Hailei Du und 5 weitere

Cancer Medicine · 2024

DOI: 10.1002/cam4.70039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Wei Guo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lymphatic Metastasis, Lung Neoplasms, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Interdisciplinary Program of Shanghai Jiao Tong University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The presence of lymph node (LN) metastasis directly affects the treatment strategy for lung adenocarcinoma (LUAD). Next‐generation sequencing (NGS) has been widely used in patients with advanced LUAD to identify targeted genes, while early detection of pathologic LN metastasis using NGS has not been assessed.

Methods

Clinicopathologic features and molecular characteristics of 224 patients from Ruijin Hospital were analyzed to detect factors associated with LN metastases. Another 140 patients from Huashan Hospital were set as a test cohort.

Results

Twenty‐four out of 224 patients were found to have lymph node metastases (10.7%). Pathologic LN‐positive tumors showed higher mutant allele tumor heterogeneity ( p < 0.05), higher tumor mutation burden ( p < 0.001), as well as more frequent KEAP1 ( p = 0.001), STK11 ( p = 0.004), KRAS ( p = 0.007), CTNNB1 ( p = 0.017), TP53, and ARID2 mutations (both p = 0.02); whereas low frequency of EGFR mutation ( p = 0.005). A predictive nomogram involving male sex, solid tumor morphology, higher T stage, EGFR wild‐type, and TP53, STK11, CDKN2A, KEAP1, ARID2, KRAS, SDHA, SPEN, CTNNB1, DICER1 mutations showed outstanding efficiency in both the training cohort (AUC = 0.819) and the test cohort (AUC = 0.780).

Conclusion

This study suggests that the integration of genomic profiling and clinical features identifies early‐invasive LUAD patients at higher risk of LN metastasis. Improved identification of LN metastasis is beneficial for the optimization of the patient's therapy decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLymphatic MetastasisLung NeoplasmsMutationHumansMaleFemaleMiddle AgedAgedHigh-Throughput Nucleotide SequencingBiomarkers, TumorNomogramsAdultGene Expression ProfilingGenomics

Stichwörter der Autor:innen

lung adenocarcinomalymph node metastasisnext‐generation sequencingprediction model

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Genecast Biotechnology Co., Ltd, Wuxi, China.

ORCID-Profile: Wei Guo, Tong Lu, Xijia Feng, Hecheng Li

Förderung

  • National Key Research and Development Program of China
  • Interdisciplinary Program of Shanghai Jiao Tong University
  • National Natural Science Foundation of China
  • Shanghai Municipal Education Commission - Gaofeng Clinical Medicine Grant
  • Shanghai Sailing Program
  • Novel Interdisciplinary Research Project from Shanghai Municipal Health Commission

Zitieren

APA

Guo, W., Lu, T., Song, Y., Li, A., Feng, X., Han, D., Cao, Y., Sun, D., Gong, X., Li, C., Jin, R., Du, H., Chen, K., Xiang, J., Hang, J., Chen, G., & Li, H. (2024). Lymph node metastasis in early invasive lung adenocarcinoma: Prediction model establishment and validation based on genomic profiling and clinicopathologic characteristics. Cancer Medicine. https://doi.org/10.1002/cam4.70039

Vancouver

Guo W, Lu T, Song Y, Li A, Feng X, Han D, et al. Lymph node metastasis in early invasive lung adenocarcinoma: Prediction model establishment and validation based on genomic profiling and clinicopathologic characteristics. Cancer Medicine. 2024. doi:10.1002/cam4.70039

BibTeX
@article{Guo2024,
  author = {Guo, Wei and Lu, Tong and Song, Yang and Li, Anqi and Feng, Xijia and Han, Dingpei and Cao, Yuqin and Sun, Debin and Gong, Xiaoli and Li, Chengqiang and Jin, Runsen and Du, Hailei and Chen, Kai and Xiang, Jie and Hang, Junbiao and Chen, Gang and Li, Hecheng},
  title = {Lymph node metastasis in early invasive lung adenocarcinoma: Prediction model establishment and validation based on genomic profiling and clinicopathologic characteristics},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70039}
}
Kostenlos starten →